Trial intelligence / Profile preview

Moexipril in Primary Biliary Cirrhosis

NCT00588302Phase 2Completed

Sponsor
Mayo Clinic
Start
Jun 2003
Primary completion
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Moexiprilat in primary biliary cholangitis (PBC), sponsored by Mayo Clinic. Started Jun 2003; status: completed.

02

Drugs

Moexiprilat
03

Conditions

primary biliary cholangitis (PBC)

Beyond the preview

Go deeper on NCT00588302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00588302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call